Related Experiment Video
Updated: Aug 15, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
A functionally inactive p53 Li-Fraumeni syndrome mutant
1Department of Molecular Genetics, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Abstract:
Germline mutations in the tumor-suppressor p53 have been recently identified in Li-Fraumeni syndrome patients. We analysed the function of one of these mutations, an arg-to-trp substitution at amino acid 245 in the murine p53 gene. This p53LFS mutant could not, unlike wild-type p53, suppress foci formation of rat embryo-fibroblasts. Like other p53 mutants it cooperated with activated ras to transform rat embryo fibroblasts. Overexpression of p53LFS thus resulted in a phenotype similar to other mutant p53s. The p53LFS protein was also transcriptionally inactive in contrast to previous studies using a p53LFS/GAL4 fusion protein. To better understand the functional domain disrupted in p53LFS, we developed a dimerization assay and showed that p53LFS still dimerized. In addition, p53LFS retained its ability to bind SV40 large T antigen and not hsc70, both characteristics of wild-type p53. Using immunofluorescence, we localized p53LFS to the nucleus. From these results we conclude that p53LFS represents an unusual p53 mutant in that it retains many characteristics of wild-type p53, however activities critical for growth suppression are lost.
Insights
Li-Fraumeni syndrome is linked to tumor-suppressor p53 mutations. This study shows a specific p53LFS mutant retains some wild-type p53 functions but loses critical growth suppression abilities.
Area of Science:
- Molecular Biology
- Cancer Genetics
Background:
- Germline mutations in the tumor-suppressor p53 gene are associated with Li-Fraumeni syndrome.
- Understanding the functional impact of these mutations is crucial for comprehending cancer development.
Purpose of the Study:
- To analyze the functional consequences of a specific p53 mutation (Arg-to-Trp at amino acid 245) found in Li-Fraumeni syndrome patients.
- To investigate the disrupted functional domains within the p53LFS mutant protein.
Main Methods:
- Functional assays including foci formation and cell transformation assays with rat embryo fibroblasts.
- Dimerization assays to assess protein-protein interactions.
- Analysis of binding affinities to SV40 large T antigen and hsc70.
- Immunofluorescence to determine subcellular localization.
Main Results:
- The p53LFS mutant failed to suppress foci formation in rat embryo fibroblasts, unlike wild-type p53.
- p53LFS cooperated with activated Ras to transform fibroblasts, exhibiting a phenotype similar to other p53 mutants.
- The mutant protein was transcriptionally inactive.
- p53LFS retained dimerization ability, nuclear localization, and binding to SV40 large T antigen, but not hsc70.
Conclusions:
- The p53LFS mutant is unusual as it retains several wild-type p53 characteristics, including dimerization and nuclear localization.
- Despite retaining some wild-type features, critical growth suppression activities are lost in the p53LFS mutant.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage Can Stall the Cell Cycle